Last reviewed · How we verify
NCT03268850
Living Kidney Donor Lost Wages Trial
NA trial testing Standard of Care in Kidney Diseases in 453 participants. Completed in 1 May 2023.
1 May 2023
Quick facts
| Lead sponsor | Beth Israel Deaconess Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 453 |
| Start date | 5 February 2018 |
| Primary completion | 1 May 2023 |
| Estimated completion | 1 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Standard of Care
- Wage Reimbursement A
- Wage Reimbursement B
Conditions studied
- Kidney Diseases — all drugs for Kidney Diseases →
Sponsor
Beth Israel Deaconess Medical Center
Who can join
18 and older, any sex, with Kidney Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effectiveness of offering reimbursement for living donor lost wages on the rate of live donor kidney transplantation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Living Donor Lost Wages Trial: Study Rationale and Protocol.
Rodrigue JR, Fleishman A, Carroll M, Evenson AR, et al · · 2018 · cited 8× · PMID 29805957 · DOI 10.1007/s40472-018-0182-0
Verify or expand the search:
- PubMed search for NCT03268850
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard of Care
Trials testing the same drug.
- NCT07337655 — Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker · Phase 2, PHASE3 · not yet recruiting
- NCT07018466 — Tele-Exercise for MERP · NA · not yet recruiting
- NCT06930768 — Evaluating the Efficacy of NeoThelium FT in the Treatment of Venous Leg Ulcers · NA · not yet recruiting
- NCT06918548 — Evaluating the Efficacy of NeoThelium FT in the Treatment of Pressure Injuries · NA · not yet recruiting
- NCT07094308 — The LIFT-ECHO Last Mile Project · NA · not yet recruiting
Other recruiting trials for Kidney Diseases
Currently open trials in the same condition.
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
- NCT07217535 — Rutgers University Study of the Genetics of Kidney Disease · recruiting
- NCT06858319 — Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. · Phase 3 · recruiting
- NCT06798909 — Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients · Phase 3 · recruiting
- NCT06759077 — Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life · Phase 3 · active not recruiting
Other Beth Israel Deaconess Medical Center trials
Trials by the same sponsor.
- NCT07352657 — Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices: The RAPTOR-CIED Study (Main Phase) · NA · not yet recruiting
- NCT07531602 — Effect of PEEP on Cardiac Function · NA · not yet recruiting
- NCT07534683 — Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological an · NA · not yet recruiting
- NCT07277244 — Low-Intensity Mechanical Ventilation in the Operating Room: a Pilot Study · NA · enrolling by invitation
- NCT06896474 — SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03268850 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beth Israel Deaconess Medical Center
- Last refreshed: 18 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03268850.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing